Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?

Hyperlipidemia is a powerful risk factor for coronary heart disease (CHD). It has been known for a long time that lipid-lowering drugs significantly reduce morbidity from CHD, thus proving a causal role for cholesterol in coronary events. Conversely, the relationship between low-density lipoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales: Temporelli, Pier Luigi, Arca, Marcello, D’Erasmo, Laura, De Caterina, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926692/
https://www.ncbi.nlm.nih.gov/pubmed/33671688
http://dx.doi.org/10.3390/jcm10040886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926692/
https://www.ncbi.nlm.nih.gov/pubmed/33671688
http://dx.doi.org/10.3390/jcm10040886

Ejemplares similares